Brain surgery breakthrough? new study tests sugar control to stop infections
NCT ID NCT07548112
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether keeping blood sugar tightly controlled after brain surgery can reduce surgical site infections. About 544 adults having elective clean brain surgery will be randomly assigned to either intensive insulin therapy (target 140-180 mg/dL) or standard care (81-180 mg/dL). The main goal is to see if fewer infections occur within 90 days after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- intensive glycemic control (continuous insulin infusion)
- What this could lead to
- If it works, this could establish a simple, low-cost way to prevent infections after brain surgery.
- What could go wrong
- This is a single-center trial not yet recruiting. Intensive glucose control may increase the risk of dangerously low blood sugar.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGICAL SITE INFECTION (SSI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple drain may slash wound infections after gynecologic cancer surgery
- Drone Warfare's hidden toll: new study tracks infection risk in combat wounds
- Vacuum bandage may shield ECMO patients from wound infections
- Wound injection may slash infection risk in emergency abdominal surgery
- New antibiotic dosing method could cut infections after heart surgery
- New rinse aims to cut infection risk in spine surgery